Please login to the form below

Not currently logged in
Email:
Password:

PhRMA appoints new EVP of public affairs

The Pharmaceutical Research and Manufacturers of America has appointed Josephine Martin as executive vice president, public affairs
The Pharmaceutical Research and Manufacturers of America (PhRMA) has appointed Josephine Martin as executive vice president, public affairs, reporting to PhRMA president and CEO John J Castellani, with effect from March 1, 2011. 

Martin, former senior vice president of public affairs at Ketchum, will be responsible for leading and managing PhRMA's communications and alliance development functions. 

Before joining Ketchum, Martin held leading public affairs positions at Golin Harris and National Media, Inc. Her health policy communications experience was developed earlier in her career as senior vice president, public affairs for the Federation of American Hospitals, and vice president of communications at the American Red Cross.

"We are thrilled to have Josie join our team at PhRMA. She brings extensive and successful experience in DC public affairs – with a particular strength in health policy communications," Castellani said. 

Commenting on her appointment, Martin said: "There are few, if any, American industries that positively impact people's lives in so many ways -- from improving health and productivity to providing good jobs, to strengthening local and national economies – as the biopharmaceutical sector." 

"I am excited to join such an energised, impactful organisation as PhRMA, and I relish the chance to bring my experience to bear as we work to best convey the tremendous value of this innovative sector," she continued.

7th February 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics